- Teladoc still remains about 50% below its ATH even though the market has continued to make new highs recently.
- In this article, we discuss how the company outperformed the telehealth market in Q1’21, which clearly demonstrated the strength of its business model.
- Even though Teladoc’s stock price is struggling, its business performances are not, and the company is also expected to be EBIT and FCF profitable soon.
- We encourage investors to take full advantage of the current volatility to add this potential long-term leader.
For further details see:
Teladoc: The Stock Is Struggling But The Business Is Not